| Filings | Filing Date | Form Type | Company | Description | AI | Link |
|---|---|---|---|---|---|---|
| Filings | Description | AI | Link | |||
|---|---|---|---|---|---|---|
 OPYOPPENHEIMER HOLDINGS INC 1.01Material agreement2.03Direct financial obligation7.01Reg FD+1Exhibits:EX-10.1EX-99.1 | Nov 9, 202610:43 AM ET | 8-K | OPY OPPENHEIMER HOLDINGS INC | 1.01Material agreement2.03Direct financial obligation7.01Reg FD+1Exhibits:EX-10.1EX-99.1 | ||
 GRABGrab Holdings Ltd Exhibits:EX-99.1EX-99.2 | Nov 9, 202610:41 AM ET | 6-K | GRAB Grab Holdings Ltd | Exhibits:EX-99.1EX-99.2 | ||
GRABGrab Holdings Ltd Exhibits:EX-99.1EX-99.2 | Nov 9, 202610:38 AM ET | 6-K | GRAB Grab Holdings Ltd | Exhibits:EX-99.1EX-99.2 | ||
Amplify ETF Trust | Nov 9, 202610:33 AM ET | 13D/A | Amplify ETF Trust | |||
 UAMYUNITED STATES ANTIMONY CORP 8.01Other events9.01ExhibitsExhibits:EX-99.1 | Nov 9, 202610:18 AM ET | 8-K | UAMY UNITED STATES ANTIMONY CORP | 8.01Other events9.01ExhibitsExhibits:EX-99.1 United States Antimony Corporation (NYSE: UAMY) filed an 8-K on November 9, 2026 announcing that it will release its third quarter 2026 financial and operating results after market… | ||
 CINFCINCINNATI FINANCIAL CORP 7.01Reg FD9.01ExhibitsExhibits:EX-99.1 | Nov 9, 202610:13 AM ET | 8-K | CINF CINCINNATI FINANCIAL CORP | 7.01Reg FD9.01ExhibitsExhibits:EX-99.1 Cincinnati Financial Corporation filed an 8-K furnishing investor presentation slides (Item 7.01) to be used in investor meetings beginning November 10, 2026.
The deck recaps prev… | ||
Quantum Space, LLC | Nov 9, 202610:12 AM ET | 425 | Quantum Space, LLC | Quantum Space announced a Virtual Analyst & Investor Day on November 9, 2026, ahead of its proposed business combination with Inflection Point Acquisition Corp. VI (Nasdaq: IPFX).… | ||
 IPFXQuantum Space, LLC | Nov 9, 202610:12 AM ET | 425 | IPFX Quantum Space, LLC | Quantum Space, the merger target of Inflection Point Acquisition Corp. VI, announced it is part of an Arrow Science and Technology-led team awarded $185 million under NASA's Moon B… | ||
 CCEPCOCA-COLA EUROPACIFIC PARTNERS plc | Nov 9, 202610:06 AM ET | 6-K | CCEP COCA-COLA EUROPACIFIC PARTNERS plc | |||
Monroe Capital Enhanced Corporate Lending Fund 1.02Agreement terminated3.02Unregistered sale8.01Other events+1Exhibits:EX-10.1EX-10.2 | Nov 9, 202610:03 AM ET | 8-K | Monroe Capital Enhanced Corporate Lending Fund | 1.02Agreement terminated3.02Unregistered sale8.01Other events+1Exhibits:EX-10.1EX-10.2 On November 2, 2026, Monroe Capital Enhanced Corporate Lending Fund terminated its December 2025 Escrow Agreement with InspereX, Ultimus Fund Solutions, and U.S. Bank after achievi… | ||
 HMYHARMONY GOLD MINING CO LTD | Nov 9, 202610:01 AM ET | 6-K | HMY HARMONY GOLD MINING CO LTD | |||
 ONCYONCOLYTICS BIOTECH INC 8.01Other eventsExhibits:EX-99.1 | Nov 9, 20269:49 AM ET | 8-K | ONCY ONCOLYTICS BIOTECH INC | 8.01Other eventsExhibits:EX-99.1 Oncolytics Biotech (Nasdaq: ONCY) announced translational data showing pelareorep's immune-engaging activity in relapsed/refractory multiple myeloma patients, to be presented as po… | ||
 VBNKVersaBank Exhibits:EX-99.1 | Nov 9, 20269:44 AM ET | 6-K | VBNK VersaBank | Exhibits:EX-99.1 | ||
 CXDOCrexendo, Inc. 7.01Reg FD9.01ExhibitsExhibits:EX-99.1 | Nov 9, 20269:31 AM ET | 8-K | CXDO Crexendo, Inc. | 7.01Reg FD9.01ExhibitsExhibits:EX-99.1 Crexendo, Inc. filed an 8-K on November 9, 2026 furnishing an investor presentation posted to its website under Item 7.01 Regulation FD Disclosure.
The presentation is attached as… | ||
 HIHOHIGHWAY HOLDINGS LTD | Nov 9, 20269:30 AM ET | 13D | HIHO HIGHWAY HOLDINGS LTD | |||
 RBNERobin Energy Ltd. | Nov 9, 20269:30 AM ET | 6-K | RBNE Robin Energy Ltd. | |||
 XLABExascale Labs Holdings Inc. 1.01Material agreement9.01ExhibitsExhibits:EX-10.1EX-10.2+4 | Nov 9, 20269:23 AM ET | 8-K | XLAB Exascale Labs Holdings Inc. | 1.01Material agreement9.01ExhibitsExhibits:EX-10.1EX-10.2+4 | ||
 HOWLWerewolf Therapeutics, Inc. 7.01Reg FD9.01ExhibitsExhibits:EX-99.1 | Nov 9, 20269:22 AM ET | 8-K | HOWL Werewolf Therapeutics, Inc. | 7.01Reg FD9.01ExhibitsExhibits:EX-99.1 Werewolf Therapeutics presented new clinical data at SITC 2026 for its conditionally activated IL-2 (WTX-124) and IL-12 (WTX-330) INDUKINE molecules, both showing antitumor activit… | ||
 NKTXNkarta, Inc. 7.01Reg FD8.01Other events9.01ExhibitsExhibits:EX-99.1EX-99.2 | Nov 9, 20269:20 AM ET | 8-K | NKTX Nkarta, Inc. | 7.01Reg FD8.01Other events9.01ExhibitsExhibits:EX-99.1EX-99.2 Nkarta announced positive initial clinical data for NKX019, its off-the-shelf CD19-directed CAR NK cell therapy, from the Ntrust-2 study in myositis and systemic sclerosis, present… | ||
 ECECOPETROL S.A. Exhibits:EX-99.1 | Nov 9, 20269:19 AM ET | 6-K | EC ECOPETROL S.A. | Exhibits:EX-99.1 |
Searching Signal8’s SEC filing archive — filings from Oct 2021 onward.
1-20 of 10,000+ filings